30/01/2020 - Research

The Immunopathology Group part of a European consortium developing cellular immunotherapies

The official kick-off meeting of the consortium INsTRuCT (INnovative Training in myeloid Regulatory Cell Therapy) took place this week in Regensburg, Germany and Dr Eva Martínez-Cáceres, Head of the Immunopathology Research Group, took part. InsTRuCT is a Marie Skłodowska-Curie Action, within the Horizon 2020 research funding programme. Its members are European researchers from the areas of academia and business and their aim is to carry out basic and clinical research to develop immunotherapies based on myeloid regulatory cells (MRC).

17/09/2018 - Campus Can Ruti, Projects, Research

Germans Trias researchers lead an international clinical trial to halt the advance of multiple sclerosis using cell therapy

A team of researchers from the Germans Trias i Pujol Hospital and Institute on the Can Ruti Campus, have started a phase I trial to slow the progress of multiple sclerosis (MS) with a cell product that uses the patient's own cells and reprograms their immune system.

06/08/2018 - Campus Can Ruti, Institutional

The IGTP provides a great opportunity to school students studying science

This summer 11 students, from Badalona, Barcelona and Mollet are carrying out the practical part of their research projects for Baccalaureate through the IGTP Summer Programme in conjunction with the Organizers of the Badalona Scientific Workshops for schools

09/07/2018 - Projects, Research

The IGTP closes its successful coordination of a COST Project to develop cellular therapies

Since 2007 the Immunopathology Group led by Dr Eva Martínez-Cáceres and Dr Cristian Ramo Tello at the IGTP has been working to develop a new treatment for autoimmune diseases, in this case for multiple sclerosis.  To help their work in this task, Dr Martinez Cáceres has coordinated a COST project, a European network of scientists working on similar problems; the project concluded in 2017 and has now published its scientific report.

16/10/2017 - Institutional

The IGTP hosts the closing conference for experts in Cellular Therapy for the COST-AFACTT Action

The final conference for the project AFACTT (BM1305) (Action to Focus and Accelerate Cell-based Tolerance-inducing Therapies) took place in Barcelona 9-11 October